Novanta Posts Record Q4 Revenue, Unveils Precision Tech Expansion Plans
Novanta achieved record Q4 2025 revenue driven by strong photonics and medical device demand and outlined targeted acquisitions in advanced precision technologies. Management plans to expand manufacturing capacity and pursue market-specific M&A to capitalize on accelerating growth in life sciences and industrial automation.
1. Q4 2025 Record Revenue and Strategic Outlook
Novanta delivered its highest quarterly revenue on record in Q4 2025, fueled by robust orders in photonics and medical device components. Management highlighted plans to expand advanced precision manufacturing capacity and pursue targeted acquisitions in life sciences and industrial automation to sustain momentum and address rising end-market demand.
Related News
CNS
Cohen & Steers Partners with J.P. Morgan on Short-Duration Hybrid Credit Fund Expansion
CNS•
MMYT
MakeMyTrip Q4 Cash Hits $782M with 1.82% Margin and 15.2% Accommodation Growth
MMYT•
GOOGL
OpenAI Plans Fall IPO After Legal Win, Intensifying AI Competition
GOOGL•
VBCJ
Vanguard BondBuilder Corporate ETFs amass $242M, boosting segment to $70B
VBCJ•
MSFT
Microsoft’s AI Spending Drives 50% of Nvidia’s $38 B Data Center Revenue
MSFT•
Sources
FFSF